FUT5 and neoplasm: Moreover, mice inoculated with orthotopic or i.p. xenograft (Fig. 6d) of M-CSCs carrying FUT5 shRNA had significantly reduced metastatic implants and ascites formation in the peritoneal cavity when compared with mice injected with nonspecific (NS) shRNA M-CSCs (Supplementary Table 5), with no apparent difference in primary tumor growth (Fig. 6e, f).